Establish the uSI Values and End-user Training Material That Will be Used to Guide Oxytocin Dosing Actions
试验速览
- 阶段
- 早期 1 期
- 发起方
- PreTeL, Inc
- 入组人数
- 51
- 试验地点
- 2
- 主要终点
- Correlating uSI with the optimized dosing actions increase, hold and decrease
研究概览
简要总结
Patients receiving oxytocin for induction or augmentation of labor will be studied with uterine EMG. The results of the EMG will be converted to an oxytocin-associated uterine stimulation index (uSI), which is intended to guide decisions for changing the dose of oxytocin. An expert panel will review the results of the oxytocin dosing actions, then assigned optimized actions throughout the labor. The uSI will be correlated with the optimal dosing actions.
详细描述
Background. Oxytocin stimulates the uterus, increases the strength and frequency of uterine contractions and facilitates delivery. The "dose" of oxytocin is the rate of IV infusion. In a typical labor where oxytocin is used, many dosing adjustments are performed over many hours. Finding the correct dose for a given patient is challenging because some women respond rapidly to low doses of oxytocin, others require high doses. The correct dose is important because the risks of adverse outcomes increase when doses are either too low or excessive. The dosing actions increase, hold, decrease or stop are typically performed every 30 minutes during oxytocin administration.
Dosing actions are performed based on the current level of simulation caused by the current dose. To assess the level of stimulation, current methods rely heavily on the output of the fetal monitor, which produces contraction frequency and fetal heart rate. Additional information for dosing decisions is obtained from subjective assessments such uterine palpation. Subjective measures are used because there is no objective method available to reliably guide a dosing action. Subjectivity is a major contributor to the long duration of labor for inductions and the high rate of excessive uterine stimulation with any oxytocin use.
The uterine stimulation index (uSI) is an objective measure of the current level of stimulation caused by the current dose of oxytocin in individual patients and can be used to guide oxytocin dosing actions. uSI is based on an electromyography (EMG) signal that is proportional to the effects of oxytocin on the uterine muscle. uSI is calculated from multichannel EMG to obtain a representative sampling of the effects of oxytocin on entire uterus. The range of values for uSI is from 0 (no oxytocin effects) to 10 (maximal oxytocin effects). Low values of uSI guide the end-user to increase the current dose of oxytocin. Intermediate values of uSI guide the end-user to hold the current dose. High values of uSI guide the end-user to decrease the current dose.
The purpose of this study is to establish the ranges of uSI values that correspond to the dosing actions increase, hold and decrease. To establish these ranges, 51 subjects will undergo current methods of dosing while having multichannel EMG recorded. uSI values will not be available to end-users, so all subjects will receive dosing actions determined by standard of care using current method. After delivery, a panel of experts will retrospectively assess each dosing action based on the outcome of the dosing action. These "optimized dosing actions" will then be correlated with the uSI value obtained at that time. This process produces paired data of optimized actions and uSI values. From the clustering of the uSI values, the ranges of uSI can be matched to the dosing actions increase, hold and decrease.
As a second goal, human factors will be studied with questionnaires and end-user interviews to improve the methods used for recording multichannel EMG during labor.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 50 Years(Adult)
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Age 18 or greater
- •At least 37 weeks gestation
- •English reading and speaking
- •Female gender
- •Singleton fetus
- •Planned continuous external fetal monitoring: to include fetal heart rate and uterine contraction monitoring
- •May have clinical indications for internal monitoring (IUPC and/or FSE) that replaces external monitoring.
- •Induction or augmentation of labor with oxytocin (Pitocin)
- •Subjects undergoing artificial rupture of membranes (AROM) or who experienced spontaneous rupture of membranes (SROM), with a plan for oxytocin administration, will be included as a special category.
- •Subjects may undergo cervical ripening.
- •Patients must be able to review and sign informed consent to participate in the study.
- •Trial of labor after Cesarean section are eligible for participation
- •Women diagnosed with diabetes and/or pre-eclampsia with or without magnesium therapy are eligible for participation
- •Women with other complications of pregnancy are eligible for participation if the complication does not interfere with fetal monitoring, EMG monitoring or other recording of data.
排除标准
- •Non-English reading and/or speaking
- •Twins, triplets and other multifetal gestations
- •Non-vertex presentation
- •Planned Cesarean delivery
- •Significant uterine anomalies such as didelphys or bicornuate uterus (women with small, clinically insignificant anomalies such as uterine fibroids are not excluded).
- •Participants cannot be participating in any other research study or protocol regarding uterine contraction monitoring during the same study period as required for our study.
- •Known allergy to ECG pad adhesive
- •Non-living fetus
- •Major fetal malformation
- •Fetal distress, or other indications for emergent delivery
- •Other than a Category I fetal heart tracing at the beginning of the recording.
结局指标
主要结局
Correlating uSI with the optimized dosing actions increase, hold and decrease
时间窗: 8 months
uSI clustering with dosing actions will be identified to provide guidance when prospectively dosing oxytocin
Human factors in recording multichannel EMG during labor
时间窗: 8 months
Difficulties and discomfort of the EMG recording process will be identified and corrected
次要结局
未报告次要终点
